Analysis of registered cases of acute fl accid paralysis in Stara Zagora district as a part of Polio Eradication Strategy
DOI:
https://doi.org/10.2478/AMB-2023-0026Keywords:
acute fl accid paralysis, epidemiological surveillance, poliomyelitis, eradication, risk factors, protective factorsAbstract
Poliomyelitis is the infection that, after smallpox, is a “serious candidate” for eradication worldwide. In accordance with the WHO strategy for 2022-2026, epidemiological surveillance of acute fl accid paralysis (AFP) is carried out with the aim of poliomyelitis eradication. The aim of the study is to determine the risk factors for the occurrence of AFP in children up to 15 years of age and to analyze the eff ectiveness of the established system for epidemiological surveillance of AFP, in Bulgaria. Materials and methods. All cases of AFP for the monitoring period 2012-2021, in Stara Zagora district, were studied. A questionnaire (34 questions) for sociodemographic and lifestyle possible risk factors for developing of AFP was also completed. Retrospective, descriptive and analytic cross-sectional epidemiological methods were applied. The data were analyzed using SPSS Statistics, Version 25.0 (IBM Corp. Armonk, NY, USA) (with Fisher’s exact test).
Results. There were 81 cases of Facial paralysis only, registered in the Web based system for surveillance of AFP, for Stara Zagora region, and 11 – AFP (without facial paralysis), for the period 2012- 2021, in Stara Zagora district (92 in total). The protective factors for developing of AFP from our study were signifi cantly associated to: having no history of paresis or paralysis in the past; absence of trauma; presence of central sewage near the home; absence of contact with animals; absence of consumption of unwashed fruits and vegetables.
Conclusion. It is very important to carry out systematic surveillance of AFP, in children up to 15 years, with the aim of investigating all cases as part of the Global strategy for the eradication of poliomyelitis; monitoring of the immunization coverage with polio vaccine to maintain a high level; surveillance of the waste and sewage waters, twice during the year in 6 months.
References
Argirova R, Komitova R. About vaccines – medicine and physical education. Sofia, 2012.
https://www.endpolio.org/ [Accessed 24.03.2023].
Nikolaeva-Glomb L, Stoianova A, Georgieva I. Polyomyelitis today – are there reasons for concern? 18th National Congress of Clinical Microbiology and Infections, Sofi a, 2020. Abstracts 43 p.
Ribarova N, Stoilova Y, Valkanova N, et al. Epidemiology of Infectious Diseases. Simelpress, 447, 2011.
Ordinance 21, on the Procedure, registration, notifi cation and reporting of communicable diseases, in Bulgaria, Annex 1.
Lei X, Xiao X, Wang J. Innate Immunity Evasion by Enteroviruses: Insights into Virus-Host Interaction. Viruses 2016, 8, 22; doi:10.3390/v8010022s.
https://afp.gateway.bg/ WEB based system for surveillance of acute fl accid paralysis (AFP) in Bulgaria, [Accessed 24.03.2023].
https://polioeradication.org/gpei-strategy-2022-2026/. [Accessed 24.03.2023].
Mercader-Barceló J, Otu A, Tow T. A. et al. Rare recurrences of poliomyelitis in non-endemic countries after eradication: a call for global action. Lancet Microbe 2022. https://doi.org/10.1016/S2666-5247(22)00253-1
Korsun N. Final phase in polio eradication. Modern Medicine, 2005, 4: 45-53.
Nikolaeva-Glomb L, Stoyanova A, Georgieva I. Polyomyelitis. Is eradication close? Medinfo 2020, (1). https://www.medinfo.bg/spisanie/2020/1/st atii/poliomielit-blizo-li-e-eradikacijata3078
Harvala H, Benschop KSM, Berginc N, et al., On Behalf Of The Enpen Hospital-Based Surveillance Network. European Non-Polio Enterovirus Network: Introduction of Hospital-Based Surveillance Network to Understand the True Disease Burden of Non-Polio Enterovirus and Parechovirus Infections in Europe. Microorganisms. 2021;9(9):1827. doi: 10.3390/microorganisms9091827.
Wang SM, Liu CC. Enterovirus 71: epidemiology, pathogenesis and management. Expert Rev Anti Infect Ther. 2009 Aug;7(6):735-42. doi: 10.1586/eri.09.45.
Fall A, Ndiaye N, Jallow MM, et al. Enterovirus D68 Subclade B3 Circulation in Senegal, 2016: Detection from Infl uenzalike Illness and Acute Flaccid Paralysis Surveillance. Sci Rep. 2019 Sep 25;9(1):13881. doi: 10.1038/s41598-019-50470-z.
Huang HI, Shih SR. Neurotropic Enterovirus Infections in the Central Nervous System. Viruses. 2015 Nov 24;7(11):6051-66. doi: 10.3390/v7112920.
Andrade C. Understanding relative risk, odds ratio, and related terms: as simple as it can get. J Clin Psychiatry.2015;76(7):21865.
Hoff man J. Some Epidemiological Considerations: Odds Ratio, Relative Risk, and Attributable Risk. In: Hoff man J. (ed.), Biostatistics for Medical and Biomedical Practitioners, Academic Press, 2015, 307-333, doi:10.1016/B978-0-12-802387-7.00020-2
Korsun N. Studies on the etiology of enterovirus, norovirus and rotavirus infections in Bulgaria (1999-2010), Sofi a 2012. Thesis for the degree Doctor of science.
Gill PJ, Bitnun A, Yeh EA. Acute fl accid myelitis. CMAJ. 2018 Dec 3;190(48):E1418. doi: 10.1503/cmaj.181442.
Morens DM, Folkers GK, Fauci AS. Acute Flaccid Myelitis: Something Old and Something New. mBio.2019;10(2):e00521-19. doi: 10.1128/mBio.00521-19.
Veronesi L, Colucci ME, Capobianco E, et al. Immunity status against poliomyelitis in young migrants: a seroprevalence study. Acta Biomed. 2019;90(9-S):28-34. doi: 10.23750/abm.v90i9-S.8700.
Cooper LV, Bandyopadhyay AS, Gumede N, et al. Risk factors for the spread of vaccine-derived type 2 polioviruses after global withdrawal of trivalent oral poliovirus vaccine and the eff ects of outbreak responses with monovalent vaccine: a retrospective analysis of surveillance data for 51 countries in Africa. Lancet Infect Dis. 2022; 22(2):284-294. doi: 10.1016/S1473-3099(21)00453-9.
Donia A, Hassan SU, Zhang X, et al. COVID-19 Crisis Creates Opportunity towards Global Monitoring & Surveillance. Pathogens. 2021;10(3):256. doi: 10.3390/pathogens10030256.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
You are free to share, copy and redistribute the material in any medium or format under these terms.
Journal Acta Medica Bulgarica 
